Acute severe vision decrease immediately after photodynamic therapy

Archives of Ophthalmology

Volumn 122, Issue 10, 2004, Pages 1546-1547

  Beaumont, Paul ^a   Lim, Charmaine S ^a   Chang, Andrew ^a   Kang, Kwon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

AGED; ARTICLE; CASE REPORT; CHOROID VASCULARIZATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; STEREORADIOGRAPHY; VISION TEST; VISUAL ACUITY; VISUAL IMPAIRMENT;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MACULAR DEGENERATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; VISION DISORDERS; VISUAL ACUITY;

EID: 5044233899     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.10.1546     Document Type: Article

References (8)

1. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2001;131:541-560.
2. Verteporfin Roundtable 2000 and 2001 Participants; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Principal Investigators; Verteporin in Photodynamic Therapy (VIP) Study Group Principal Investigators. Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularisation due to age-related macular degeneration and other causes. Retina. 2002;22:6-18.
3. Fingar VH. Vascular effects of photodynamic therapy. J Clin Laser Med Surg. 1996;14: 323-328.
4. Fingar VH, Wieman TJ, Haydon PS. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 1992;52:4914-4921.
5. Ben-Hur E, Heldman E, Crane SW, Rosenthal I. Release of clotting factors from photosensitized endothelial cells: a possible trigger for blood vessel occlusion by photodynamic therapy. FEBS Lett. 1988;236:105-108.
6. Foster TH, Primavera MC, Marder VF, Hilf R, Sporn LA. Photosynthesized release of von Willebrand factor from cultured human endothelial cells. Cancer Res. 1991;51:3261-3266.
7. Rodgers AH, Martidis A, Greenberg PB, Puliafito CA. Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol. 2002;134(4):566-576.
8. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP Report 1. Arch Ophthalmol. 1999;117:1329-1345.